AnaptysBio, Inc. ANAB Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s additional paid-in capital?
- AnaptysBio, Inc. (ANAB) reported additional paid-in capital of $838.31M in Q1 2026.
- How has AnaptysBio, Inc.'s additional paid-in capital changed year-over-year?
- AnaptysBio, Inc.'s additional paid-in capital increased by 0.7% year-over-year, from $832.49M to $838.31M.
- What is the long-term trend for AnaptysBio, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s additional paid-in capital has grown at a 4.2% compound annual growth rate (CAGR), from $660.67M to $809.77M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.